BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34353635)

  • 1. APOBECs orchestrate genomic and epigenomic editing across health and disease.
    Cervantes-Gracia K; Gramalla-Schmitz A; Weischedel J; Chahwan R
    Trends Genet; 2021 Nov; 37(11):1028-1043. PubMed ID: 34353635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA Editing by APOBECs: A Genomic Preserver and Transformer.
    Knisbacher BA; Gerber D; Levanon EY
    Trends Genet; 2016 Jan; 32(1):16-28. PubMed ID: 26608778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-transcriptional regulation of LINE-1 retrotransposition by AID/APOBEC and ADAR deaminases.
    Orecchini E; Frassinelli L; Galardi S; Ciafrè SA; Michienzi A
    Chromosome Res; 2018 Mar; 26(1-2):45-59. PubMed ID: 29396793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Family-Wide Comparative Analysis of Cytidine and Methylcytidine Deamination by Eleven Human APOBEC Proteins.
    Ito F; Fu Y; Kao SA; Yang H; Chen XS
    J Mol Biol; 2017 Jun; 429(12):1787-1799. PubMed ID: 28479091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the Embrace of a Mutator: APOBEC Selection of Nucleic Acid Ligands.
    Salter JD; Smith HC
    Trends Biochem Sci; 2018 Aug; 43(8):606-622. PubMed ID: 29803538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA and RNA editing of retrotransposons accelerate mammalian genome evolution.
    Knisbacher BA; Levanon EY
    Ann N Y Acad Sci; 2015 Apr; 1341():115-25. PubMed ID: 25722083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting specificity of APOBEC-based cytosine base editor in human iPSCs determined by whole genome sequencing.
    McGrath E; Shin H; Zhang L; Phue JN; Wu WW; Shen RF; Jang YY; Revollo J; Ye Z
    Nat Commun; 2019 Nov; 10(1):5353. PubMed ID: 31767844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases.
    Koito A; Ikeda T
    Front Microbiol; 2013; 4():28. PubMed ID: 23431045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like family genes activation and regulation during tumorigenesis.
    Gao J; Choudhry H; Cao W
    Cancer Sci; 2018 Aug; 109(8):2375-2382. PubMed ID: 29856501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mutagenic Activity of AID/APOBEC Deaminases in Antiviral Defense and Carcinogenesis].
    Shilova ON; Tsyba DL; Shilov ES
    Mol Biol (Mosk); 2022; 56(1):55-68. PubMed ID: 35082258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AID/APOBEC deaminases disfavor modified cytosines implicated in DNA demethylation.
    Nabel CS; Jia H; Ye Y; Shen L; Goldschmidt HL; Stivers JT; Zhang Y; Kohli RM
    Nat Chem Biol; 2012 Sep; 8(9):751-8. PubMed ID: 22772155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competition for DNA binding between the genome protector replication protein A and the genome modifying APOBEC3 single-stranded DNA deaminases.
    Wong L; Sami A; Chelico L
    Nucleic Acids Res; 2022 Nov; 50(21):12039-12057. PubMed ID: 36444883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of APOBEC-mediated RNA editing in SARS-CoV-2 mutations, replication and fitness.
    Kim K; Calabrese P; Wang S; Qin C; Rao Y; Feng P; Chen XS
    Sci Rep; 2022 Sep; 12(1):14972. PubMed ID: 36100631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The preferred nucleotide contexts of the AID/APOBEC cytidine deaminases have differential effects when mutating retrotransposon and virus sequences compared to host genes.
    Chen J; MacCarthy T
    PLoS Comput Biol; 2017 Mar; 13(3):e1005471. PubMed ID: 28362825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs regulate APOBEC gene expression.
    Cao W; Wu W
    Histol Histopathol; 2018 Feb; 33(2):117-120. PubMed ID: 28604942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential.
    Butler K; Banday AR
    J Hematol Oncol; 2023 Mar; 16(1):31. PubMed ID: 36978147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AID and APOBEC deaminases: balancing DNA damage in epigenetics and immunity.
    Franchini DM; Petersen-Mahrt SK
    Epigenomics; 2014; 6(4):427-43. PubMed ID: 25333851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review).
    He X; Li J; Wu J; Zhang M; Gao P
    Mol Med Rep; 2015 Nov; 12(5):6405-14. PubMed ID: 26398702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the Structures and Multimeric Status of APOBEC Proteins Involved in Viral Restriction and Other Cellular Functions.
    Chen XS
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33802945
    [No Abstract]   [Full Text] [Related]  

  • 20. DNA Editing of LTR Retrotransposons Reveals the Impact of APOBECs on Vertebrate Genomes.
    Knisbacher BA; Levanon EY
    Mol Biol Evol; 2016 Feb; 33(2):554-67. PubMed ID: 26541172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.